The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients

被引:61
作者
Nordoy, I [1 ]
Müller, F
Nordal, KP
Rollag, H
Lien, E
Aukrust, P
Froland, SS
机构
[1] Univ Oslo, Rikshosp, Dept Med, Res Inst Internal Med,Sect Clin & Infect Dis, N-0027 Oslo, Norway
[2] Univ Oslo, Rikshosp, Dept Med, Nephrol Sect, N-0027 Oslo, Norway
[3] Univ Oslo, Rikshosp, Dept Microbiol, N-0027 Oslo, Norway
[4] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Biol, N-7034 Trondheim, Norway
关键词
D O I
10.1086/315184
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The effects of cytomegalovirus (CMV) infection on monocyte and T cell activation and the role of the tumor necrosis factor (TNF) system and interleukin (IL)-10 were studied in a prospective study of 25 renal transplant recipients. Ten patients developed CMV disease (group A), 5 developed asymptomatic infection (group B), and 10 did not have CMV infection (group C), During CMV disease (group A), there was evidence of both monocyte and T cell activation, All patients with CMV infection (groups A and B) showed increased activation of the TNF system, concomitant with an increase in plasma levels of IL-10. Patients with CMV disease (group A) had more marked manifestations of TNF activation and more moderate IL-10 increase than patients with asymptomatic CMV infection (group B), reflected in a higher plasma IL-10/TNF-alpha ratio in asymptomatic patients. Thus, the balance between TNF-alpha and IL-10 may be important in the development of CMV infection and CMV-related disease.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 43 条
[1]
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[2]
2-4
[3]
ASANUMA H, 1995, FEMS IMMUNOL MED MIC, V12, P153, DOI 10.1111/j.1574-695X.1995.tb00187.x
[4]
Belles-Isles M, 1998, TRANSPLANTATION, V65, P279
[5]
MECHANISMS OF IMMUNOSUPPRESSION IN CYTOMEGALO-VIRUS MONONUCLEOSIS .2. VIRUS-MONOCYTE INTERACTIONS [J].
CARNEY, WP ;
HIRSCH, MS .
JOURNAL OF INFECTIOUS DISEASES, 1981, 144 (01) :47-54
[6]
Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation [J].
de Otero, J ;
Gavaldà, J ;
Murio, E ;
Vargas, V ;
Calicó, I ;
Llopart, L ;
Rosselló, J ;
Margarit, C ;
Pahissa, A .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :865-870
[7]
Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91
[8]
LPS-INDUCED RELEASE OF IL-1-BETA, IL-6, IL-8, TNF-ALPHA AND SCD14 IN WHOLE-BLOOD AND PBMC FROM PERSONS WITH HIGH OR LOW-LEVELS OF HDL-LIPOPROTEIN [J].
EGGESBO, JB ;
HJERMANN, I ;
LUND, PK ;
JOO, GB ;
OVSTEBO, R ;
KIERULF, P .
CYTOKINE, 1994, 6 (05) :521-529
[9]
FIETZE E, 1994, TRANSPLANTATION, V58, P675
[10]
THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR [J].
GRELL, M ;
DOUNI, E ;
WAJANT, H ;
LOHDEN, M ;
CLAUSS, M ;
MAXEINER, B ;
GEORGOPOULOS, S ;
LESSLAUER, W ;
KOLLIAS, G ;
PFIZENMAIER, K ;
SCHEURICH, P .
CELL, 1995, 83 (05) :793-802